You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
|
---|---|
Published in |
The Lancet Haematology, November 2022
|
DOI | 10.1016/s2352-3026(22)00292-7 |
Pubmed ID | |
Authors |
Justin M Watts, Maria R Baer, Jay Yang, Thomas Prebet, Sangmin Lee, Gary J Schiller, Shira N Dinner, Arnaud Pigneux, Pau Montesinos, Eunice S Wang, Karen P Seiter, Andrew H Wei, Stephane De Botton, Montserrat Arnan, Will Donnellan, Anthony P Schwarer, Christian Récher, Brian A Jonas, P Brent Ferrell, Christophe Marzac, Patrick Kelly, Jennifer Sweeney, Sanjeev Forsyth, Sylvie M Guichard, Julie Brevard, Patrick Henrick, Hesham Mohamed, Jorge E Cortes |
X Demographics
The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 17 | 53% |
France | 2 | 6% |
Algeria | 1 | 3% |
Hungary | 1 | 3% |
Spain | 1 | 3% |
Lithuania | 1 | 3% |
Georgia | 1 | 3% |
Unknown | 8 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 17 | 53% |
Scientists | 10 | 31% |
Science communicators (journalists, bloggers, editors) | 3 | 9% |
Practitioners (doctors, other healthcare professionals) | 2 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 39 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 5 | 13% |
Student > Bachelor | 5 | 13% |
Student > Ph. D. Student | 3 | 8% |
Unspecified | 3 | 8% |
Lecturer > Senior Lecturer | 2 | 5% |
Other | 4 | 10% |
Unknown | 17 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 15% |
Biochemistry, Genetics and Molecular Biology | 5 | 13% |
Unspecified | 3 | 8% |
Agricultural and Biological Sciences | 3 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Other | 1 | 3% |
Unknown | 20 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 321. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2023.
All research outputs
#106,954
of 25,805,386 outputs
Outputs from The Lancet Haematology
#20
of 1,291 outputs
Outputs of similar age
#3,031
of 441,955 outputs
Outputs of similar age from The Lancet Haematology
#1
of 46 outputs
Altmetric has tracked 25,805,386 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,291 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,955 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.